Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis
Authors
Yoshimi, ALin, KT
Wiseman, Daniel H
Rahman, MA
Pastore, A
Wang, B
Lee, SC
Micol, JB
Zhang, XJ
de, BS
Penard-Lacronique, V
Stein, EM
Cho, H
Miles, RE
Inoue, D
Albrecht, TR
Somervaille, Tim CP
Batta, Kiran
Amaral, Fabio
Simeoni, Fabrizio
Wilks, Deepti P
Cargo, C
Intlekofer, AM
Levine, RL
Dvinge, H
Bradley, RK
Wagner, EJ
Krainer, AR
Abdel-Wahab, O
Affiliation
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NYIssue Date
2019
Metadata
Show full item recordCitation
Yoshimi A, Lin KT, Wiseman DH, Rahman MA, Pastore A, Wang B, et al. Coordinated alterations in RNA splicing and epigenetic regulation drive leukaemogenesis. Nature. 2019.Journal
NatureDOI
10.1038/s41586-019-1618-0PubMed ID
31578525Additional Links
https://dx.doi.org/10.1038/s41586-019-1618-0Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41586-019-1618-0
Scopus Count
Collections
Related articles
- [Aberrant RNA splicing and development of hematological malignancies].
- Authors: Yoshimi A
- Issue date: 2020
- SRSF2 mutations drive oncogenesis by activating a global program of aberrant alternative splicing in hematopoietic cells.
- Authors: Liang Y, Tebaldi T, Rejeski K, Joshi P, Stefani G, Taylor A, Song Y, Vasic R, Maziarz J, Balasubramanian K, Ardasheva A, Ding A, Quattrone A, Halene S
- Issue date: 2018 Dec
- Recurrent SRSF2 mutations in MDS affect both splicing and NMD.
- Authors: Rahman MA, Lin KT, Bradley RK, Abdel-Wahab O, Krainer AR
- Issue date: 2020 Mar 1
- Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins.
- Authors: Lee SC, Dvinge H, Kim E, Cho H, Micol JB, Chung YR, Durham BH, Yoshimi A, Kim YJ, Thomas M, Lobry C, Chen CW, Pastore A, Taylor J, Wang X, Krivtsov A, Armstrong SA, Palacino J, Buonamici S, Smith PG, Bradley RK, Abdel-Wahab O
- Issue date: 2016 Jun
- Combination Targeted Therapy to Disrupt Aberrant Oncogenic Signaling and Reverse Epigenetic Dysfunction in IDH2- and TET2-Mutant Acute Myeloid Leukemia.
- Authors: Shih AH, Meydan C, Shank K, Garrett-Bakelman FE, Ward PS, Intlekofer AM, Nazir A, Stein EM, Knapp K, Glass J, Travins J, Straley K, Gliser C, Mason CE, Yen K, Thompson CB, Melnick A, Levine RL
- Issue date: 2017 May